We thank the Marsden Fund, administered by the Royal Society of New Zealand, for financial support.
1521-3773/asset/2002_left.gif?v=1&s=ac6b0d94a94d7ce7a210002b8096b42feffc0bcf)
1521-3773/asset/2002_right.gif?v=1&s=451042aa3415ae3ad0729984d26dee1866aca82e)
Communication
You have free access to this content
The Composition of Ehrlich's Salvarsan: Resolution of a Century-Old Debate†
Article first published online: 29 DEC 2004
DOI: 10.1002/anie.200461471
Copyright © 2005 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim
Additional Information
How to Cite
Lloyd, N. C., Morgan, H. W., Nicholson, B. K. and Ronimus, R. S. (2005), The Composition of Ehrlich's Salvarsan: Resolution of a Century-Old Debate. Angew. Chem. Int. Ed., 44: 941–944. doi: 10.1002/anie.200461471
- †
Publication History
- Issue published online: 25 JAN 2005
- Article first published online: 29 DEC 2004
- Manuscript Revised: 8 OCT 2004
- Manuscript Received: 29 JUL 2004
- Abstract
- Article
- References
- Cited By
Cited in:
- CrossRef
This article has been cited by:
- 1, Copper Compounds Ameliorate Cardiovasclur Dysfunction and Diabetes in Animals, YAKUGAKU ZASSHI, 2012, 132, 3, 285
- 2, Exploring the mechanisms of metalÂbased pharmacological agents via an integrated approach, Journal of Inorganic Biochemistry, 2012, 109, 97
- 3, , , Small organometallic compounds as antibacterial agents, Dalton Transactions, 2012, 41, 21, 6350
- 4
- 5, , , Arsenic and its combinations in cancer therapeutics, Therapeutic Delivery, 2011, 2, 6, 793
- 6, , , , , Arsenic Exposure and Toxicology: A Historical Perspective, Toxicological Sciences, 2011, 123, 2, 305
- 7, , Places and chemistry: Strasbourg—a chemical crucible seen through historical personalities, Chemical Society Reviews, 2011, 40, 5, 2061
- 8, , , Cien años de la bala mágica del Dr. Ehrlich (1909–2009), Enfermedades Infecciosas y MicrobiologÃa ClÃnica, 2010, 28, 8, 521
- 9, Computing the NMR spectra of the sponge metabolite arsenicin A: when simple becomes difficult, Journal of Physical Organic Chemistry, 2010, 23, 11Direct Link:
- You have free access to this content10, , Discovery and Syntheses of “Superbug Challengers”—Platensimycin and Platencin, Chemistry – An Asian Journal, 2010, 5, 4Direct Link:
- 11, , , , , Metallo–allixinate complexes with anti-diabetic and anti-metabolic syndrome activities, Metallomics, 2010, 2, 10, 670
- 12, Reflections on drug research, British Journal of Pharmacology, 2010, 161, 6Direct Link:
- 13
- 14, , , , , Computational NMR Spectroscopy of Organoarsenicals and the Natural Polyarsenic Compound Arsenicin A, Chemistry - A European Journal, 2008, 14, 33Direct Link:
- 15, , Doubly bonded systems between heavier Group 15 elements, Dalton Transactions, 2008, 11, 1395
- 16, , Medicinal Organometallic Chemistry: Designing Metal Arene Complexes as Anticancer Agents, Chemistry – An Asian Journal, 2008, 3, 11Direct Link:
- 17, , , , Substituted phenylarsonic acids; structures and spectroscopy, Journal of Organometallic Chemistry, 2008, 693, 14, 2443
- 18, Synthesis of Polymers Containing Group 15 Elements via Bismetallation of Acetylenic Compounds, Polymer Journal, 2008, 40, 11, 1031
- 19
- 20, , , , Formation of a Chiral Center and Pyrimidal Inversion at the Single-Molecule Level, Angewandte Chemie International Edition, 2007, 46, 39Direct Link:
- 21, , , , Formation of a Chiral Center and Pyrimidal Inversion at the Single-Molecule Level, Angewandte Chemie, 2007, 119, 39Direct Link:
- 22, , Stable compounds containing heavier group 15 elements in the +1 oxidation state, Coordination Chemistry Reviews, 2007, 251, 7-8, 936
- 23, , , , , , From bench to bedside – preclinical and early clinical development of the anticancer agent indazolium trans-[tetrachlorobis(1H-indazole)ruthenate(III)] (KP1019 or FFC14A), Journal of Inorganic Biochemistry, 2006, 100, 5-6, 891
- 24, , , , , , , On the First Polyarsenic Organic Compound from Nature: Arsenicin A from the New Caledonian Marine Sponge Echinochalina bargibanti, Chemistry - A European Journal, 2006, 12, 35Direct Link:
- 25, Anticancer Activity of Molecular Compounds of Arsenic, Antimony and Bismuth,Direct Link:
- 26, , , , Computational Multitarget Drug Discovery,Direct Link:
- 27, , Medicinal Inorganic Chemistry: State of the Art, New Trends, and a Vision of the Future,Direct Link:
- 28, , , , The Chemistry of Arsenic, Antimony and Bismuth,Direct Link: